← Eichor
Study identifier: NCT06703060 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Multi-Level Trauma-Informed Approach to Increase HIV Pre-exposure Prophylaxis Initiation Among Black Women

Condition: HIV Prevention · PrEP · Women  ·  Sponsor: Johns Hopkins Bloomberg School of Public Health

PhaseNA
Planned participants300
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

U.S. epidemiological data indicates that Black women are a high-risk HIV disparity group, yet initiation of novel prevention strategies like pre-exposure prophylaxis (PrEP) among this group is stagnant. Socio-structural challenges like intimate partner violence and gendered racism can constrain PrEP access among Black women, but few implementation studies have mitigated these challenges to improve PrEP initiation. The proposed research aims to implement and assess the effectiveness, implementation, and sustainability of a multilevel intervention to increase PrEP initiation among Black women with and without intimate partner violence in Baltimore.

This description comes directly from the study's public registry record.

Talk to the study team

Tiara C. Willie, PhD, MA  ·  410-614-2686  ·  twillie2@jhu.edu

Project Director, DrPH  ·  jmassie4@jhu.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Johns Hopkins Bloomberg School of Public HealthBaltimore, Maryland, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06703060